LABRHA participated in the 17th EULAR Congress which took place from the 8th to the 11th of June 2016 in London.
1) Predictive factors of failure of viscosupplementation in patients with knee Osteoarthritis. Results of a post-hoc analysis of a double blind, controlled non Inferiority trial. F. Eymard, T. Conrozier, X. Chevalier1.
This study has been conducted using the same database than the clinical trial HAppyVisc vs. Euflexxa and presented at the EULAR Congress in the session “Lubricants: potential as osteoarthritis treatment?”. The objective of this study is to identify clinical and radiographic predictive factors of treatment’s response or failure in patients treated with Viscosupplementation for Knee Osteoarthritis. Read the abstract.
An article was dedicated to this study in the Thursday Edition of the journal “EULAR Congress News”.
2) Radiographic characteristics of the hip may predict response to viscosupplementation in patients with hip osteoarthritis. Results of a prospective observational, multicenter, open-label, pilot study. F. Eymard, B. Maillet, H. Lellouche, T. Conrozier and OA group of the French Society of rheumatology and Groupe de Recherche en Rhumatologie Interventionnelle Français
The abstract of the above mentioned study has been accepted for publication and is available in the electronic “Abstract Book” which is an Official Supplement to the “Annals of Rheumatic Diseases ARD”. Read the abstract.
